Business Development

Myriad Pharmaceuticals is committed to bringing first-in-class / best-in-class therapeutics to cancer and HIV patients. To do this, we intend to develop strategic alliances with partners that can provide the expertise and resources to fully realize the potential of our novel development compounds while minimizing the risk of failure inherent to drug discovery. These collaborations will provide near-term revenue to advance our earlier stage assets into product opportunities while providing a long-term financial upside through milestone payments, royalty revenue and commercialization in the US.

If you are interested in learning more about our development candidates or collaborating with Myriad Pharmaceuticals, please contact our Business Development group:

Joshua T. Jones, Ph.D.
Manager, Business Development
(p) 801-214-7876
This e-mail address is being protected from spambots. You need JavaScript enabled to view it